BioSpace News Archive

IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study

IRRAS announced the initial patient treatments with the company’s IRRAflow system within Mount Sinai Health System in New York, NY, one of the United States’ largest and most respected hospital groups.

August 23, 2022
·
3 min read
Pharnext Announces a €2.5m Loan Agreement with Néovacs

Pharnext SA, an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, announces the signing of a €2.5 million loan agreement with Néovacs, a French biotechnology company listed on Euronext Growth Paris.

August 23, 2022
·
3 min read
Business

c-LEcta Reports Record Year With Significant Growth - Aug 23, 2022

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully continued its dynamic business development in fiscal year 2021.

August 23, 2022
·
6 min read
Immunovia to present at Gilmartin Group’s Emerging Growth Company Showcase

Immunovia announced it will participate in Gilmartin Group’s Emerging Growth Company Showcase on August 31, 2022.

August 23, 2022
·
1 min read
Business

Medtronic reports first quarter fiscal 2023 financial results

Medtronic plc announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022.

August 23, 2022
·
28 min read
Drug Development

Plus Therapeutics to Present Data from ReSPECT-GBM™ Clinical Trial at the European Society for Medical Oncology Congress 2022

Plus Therapeutics, Inc. today announced it will present data from the Phase 1/2a ReSPECT-GBM™ dose escalation clinical trial evaluating the Company’s lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome ( 186 RNL).

August 23, 2022
·
4 min read
Business

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

IsoPlexis Corporation today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director.

August 23, 2022
·
6 min read
Biotech Bay

Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Lucira Health, Inc. today announced that the company will participate in the Gilmartin Group Emerging Growth Company Showcase on August 31st , 2022.

August 23, 2022
·
1 min read
Business

GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

GH Research PLC today reported financial results for the second quarter ended June 30, 2022 and gave updates on its business.

August 23, 2022
·
7 min read
Biotech Beach

Modified bladder cancer treatment shows promise in animal studies

A modified tuberculosis vaccine developed at Texas Biomedical Research Institute could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

August 23, 2022
·
3 min read